Cardiac fluorine-18 fluorodeoxyglucose imaging using a dual-head gamma camera with coincidence detection: A clinical pilot study

European Journal of Nuclear Medicine

Volumn 27, Issue 6, 2000, Pages 676-685

  De Sutter, Johan ^a   De Winter, Frederic ^a   Van De Wiele, Christophe ^a   De Bondt, Pieter ^a   D'Asseler, Yves ^b   Dierckx, Rudi ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

Coincidence detection; Fluorine 18 fluorodeoxyglucose; Myocardial viability; Positron emission tomography; Single photon emission tomography

Indexed keywords

FLUORODEOXYGLUCOSE F 18; TETROFOSMIN TC 99M;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG UPTAKE; ECHOCARDIOGRAPHY; FEMALE; HEART FUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART SCINTISCANNING; HUMAN; MALE; PILOT STUDY; POSITRON EMISSION TOMOGRAPHY; RECEIVER OPERATING CHARACTERISTIC; SCINTILLATION CAMERA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADULT; AGED; ECHOCARDIOGRAPHY; FEMALE; FLUORODEOXYGLUCOSE F18; GAMMA CAMERAS; HEART; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; ORGANOPHOSPHORUS COMPOUNDS; ORGANOTECHNETIUM COMPOUNDS; PILOT PROJECTS; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0034051293     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590050562     Document Type: Article

References (26)

1. 1. Wijns W, Vatner SF, Camici PG. Mechanisms of disease: hibernating myocardium. N Engl J Med 1998; 339: 173-181.
2. 2. Lucignani G, Schwaiger M, Melin J, Fazio F. Assessing hibernating myocardium: an emerging cost-effectiveness issue. Eur J Nucl Med 1997; 24: 1337-1341.
3. 3. De Sutter J, Underwood R. Prognostic implications of infarct size assessed by myocardial perfusion single-photon emission tomography. Eur J Nucl Med 2000 (in press).
4. 4. Schwaiger M, Hicks R. The clinical role of metabolic imaging of the heart by positron emission tomography. J Nucl Med 1991; 32: 565-578.
5. 5. Burt RW, Perkins OW, Oppenheim BE, et al. Direct comparison of fluorine-18-FDG SPET, fluorine-18-FDG PET, rest thallium-201 SPET for detection of myocardial viability. J Nucl Med 1995; 36: 176-179.
6. 6. Bax JJ, Visser FC, Blanksma PK, et al. Comparison of myocardial uptake of fluorine-18-fluorodeoxyglucose imaged with PET and SPET in dyssynergic myocardium. J Nucl Med 1996; 37: 1631-1636.
7. 7. Chen EQ, MacIntyre WJ, Go RT, et al. Myocardial viability studies using fluorine-18-FDG SPET: a comparison with fluorine-18-FDG PET. J Nucl Med 1997; 38: 582-586.
8. 18Fluorodeoxyglucose single photon emission computed tomography. Can it replace PET and thallium SPET for the assessment of myocardial viability? Circulation 1998; 97: 843-850.
9. 9. Udelson JE. Steps forward in the assessment of myocardial viability in left ventricular dysfunction. Circulation 1998; 97: 833-838.
10. 10. Sandler MP, Bax JJ, Patton JA, Visser FC, Martin WH, Wijns W. Fluorine-18-fluorodeoxyglucose cardiac imaging using a modified scintillation camera. J Nucl Med 1998; 39: 2035-2043.
11. 11. Lewellen TK, Miyaoka RS, Swan WL. PET imaging using dual-headed gamma cameras: an update. Nucl Med Commun 1999; 20: 5-12.
12. 12. Boren EL Jr, Delbeke D, Patton JA, Sandler MP. Comparison of FDG PET and positron coincidence detection imaging using a dual-head gamma camera with 5/8-inch NaI(T1) crystals in patients with suspected body malignancies. Eur J Nucl Med 1999; 26: 379-387.
13. 13. Tatsumi M, Yutani K, Watanabe Y, et al. Feasibility of fluorodeoxyglucose dual-head gamma camera coincidence imaging in the evaluation of lung cancer: comparison with FDG PET. J Nucl Med 1999; 40: 566-573.
14. 18F-fluorodeoxyglucose imaging with a dual-head coincidence gamma camera for detection of myocardial viability. J Nucl Med 1999; 40: 1884-1892.
15. 15. Knuuti MJ, Yki-Järvinen H, Voipo-Pulkki LM, et al. Enhancement of myocardial fluorine-18-fluorodeoxyglucose uptake by a nicotinic acid derivative. J Nucl Med 1994; 35: 989-998.
16. 16. Bax JJ, Veening MA, Visser FC, et al. Optimal metabolic conditions during fluorine-18 fluorodeoxyglucose imaging; a comparative study using different protocols. Eur J Nucl Med 1997; 24: 35-41.
17. 17. Vandenberghe S, D'Asseler Y, Koole M, et al. Physical evaluation of 511 keV imaging with gamma camera and PET. Comput Med Imaging Graph (in press).
18. 18. Chang LT. A method for attenuation correction in radionuclide computed tomography. IEEE Trans Nucl Sci 1978; 26: 638-643.
19. 19. Gulberg GT, Budinger TF. The use of filtering methods to compensate for constant attenuation in single-photon emission computed tomography. IEEE Trans Biomed Eng 1981; 28: 142-157.
20. 20. Hachamovitch R, Berman DS, Shaw LJ, et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratification for risk of cardiac death and myocardial infarction. Circulation 1998; 97: 535-543.
21. 21. Martin WH, Jones RC, Delbeke D, Sandler MP. A simplified intravenous glucose loading protocol for fluorine-18 fluorodeoxyglucose cardiac single-photon emission tomography. Eur J Nucl Med 1997; 24: 1291-1297.
22. 22. Bax JJ, Wijns W. Fluorodeoxyglucose imaging to assess myocardial viability: PET, SPET or gamma camera coincidence imaging? J Nucl Med 1999: 40: 1893-1895.
23. 23. Srinivasan G, Bacharach SL, Kitsiou AN, Nour KA, Davis CM, Dilsizian V. Delayed FDG imaging improves myocardial/blood pool contrast [abstract]. J Am Coll Cardiol 1997; 29: 436A.
24. 18F fluorodeoxyglucose in patients with chronic coronary artery disease. A functional and morphological approach to the detection of residual myocardial viability. Circulation 1995; 91: 1006-1015.
25. 25. Chan RKM, Lee KJ, Calafiore P, Berlangieri SU, McKay WJ, Tonkin AM. Comparison of dobutamine echocardiography and positron emission tomography in patients with chronic ischemic left ventricular dysfunction. J Am Coll Cardiol 1996; 27: 1601-1607.
26. 26. Bax JJ, Wijns W, Cornel JH, Visser FC, Boersma E, Fioretti PM. Accuracy of currently available techniques for prediction of functional recovery after revascularisation in patients with left ventricular dysfunction due to chronic coronary artery disease: comparison of pooled data. J Am Coll Cardiol 1997; 30: 1451-1460.